/
AOLS
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
100% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $4.8M | $7.3M | $3.9M | $9.6M | $3.1M | $2.1M |
| Cost of revenue | $0 | $0 | $0 | $0 | $3.4M | $7.0M | $3.5M | $2.9M |
| Gross profit | $0 | $0 | $4.8M | $7.3M | $568.0K | $2.7M | −$398.0K | −$805.0K |
| Gross margin | — | — | 100.0% | 100.0% | 14.5% | 27.7% | -12.8% | -38.8% |
| R&D | $711.0K | $1.7M | $5.1M | $6.5M | $3.4M | $7.0M | $3.5M | $2.9M |
| Operating income | −$2.0M | −$3.6M | −$3.9M | −$2.4M | −$2.7M | −$80.0K | −$2.6M | −$3.3M |
| EBITDA | −$1.9M | $17.7M | $325.0K | −$2.4M | −$2.7M | −$80.0K | −$2.6M | −$3.3M |
| Net income | −$2.3M | −$25.9M | $299.0K | $1.7M | −$3.2M | −$80.0K | −$2.6M | −$3.6M |
| Net margin | — | — | 6.2% | 23.3% | -81.7% | -0.8% | -84.5% | -171.4% |
| EPS (diluted) | -0.07 | -0.53 | 0.00 | -0.03 | -0.03 | -0.00 | -0.02 | -0.04 |
Annual figures · source: Financial Modeling Prep
Peer comparison
AEOLUS PHARMS INC
AEOLUS PHARMS INC
Held by traders on TradeandTell
No one on the platform currently holds AOLS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in AOLS as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded AOLS yet.